AstraZeneca stock rating reiterated at Buy by Guggenheim ahead of Q4 results

Investing.com - Guggenheim has reiterated its Buy rating on AstraZeneca (NASDAQ:AZN) (AZN:LN) with a price target of ...
Precision Medicine Online

AstraZeneca Emphasizes Growth Potential From ADC Pipeline, Approved Cancer Drugs at JPM

The firm expects Phase III data for its investigational selective estrogen receptor degrader camizestrant and its CLDN18.2 ADC sonesitatug vedotin this year.
MedPage Today

Navigating Options After CDK4/6 Inhibition in Metastatic Breast Cancer

Clinicians treating patients with estrogen receptor (ER)-positive/HER2-negative metastatic breast cancer are navigating ...

AstraZeneca: Oncology Dominance Justifies New All-Time Highs

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

Nadia Sawalha fights back tears on Loose Women as she pays poignant tribute to 'brave and selfless' late friend, 39, who died of breast cancer

Loose Women star Nadia Sawalha fought back tears as she paid tribute to her 'brave and selfless' friend who sadly passed away ...